EMA Authorised: Posaconazole AHCL (posaconazole) — Accord Healthcare S.L.U.

View source ↗

Summary

EMA authorised Posaconazole AHCL by Accord Healthcare S.L.U. for mycoses. The EU marketing authorization was granted on 16 January 2025.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candidiasis
• Invasive Aspergillosis
• Mucormycosis
• Oropharyngeal Candidiasis

Drugs mentioned

• Posaconazole AHCL (posaconazole)

Snippet

Status: Authorised. Therapeutic area: Mycoses. MAH: Accord Healthcare S.L.U.. Decision date: 16/01/2025